Trial intelligence / Profile preview

Axitinib and Carboplatin/Paclitaxel in Melanoma

NCT01174238Phase 2Completed

Start
Jul 2010
Primary completion
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of axitinib in melanoma. Started Jul 2010; status: completed.

02

Drugs

axitinib
03

Conditions

melanoma

Beyond the preview

Go deeper on NCT01174238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01174238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call